2021
Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study
Justice AC, Gordon KS, Romero J, Edelman EJ, Garcia BJ, Jones P, Khoo S, Re V, Rentsch CT, Tate JP, Tseng A, Womack J, Jacobson D. Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study. The Lancet Healthy Longevity 2021, 2: e639-e650. PMID: 34870254, PMCID: PMC8639138, DOI: 10.1016/s2666-7568(21)00206-3.Peer-Reviewed Original ResearchMeSH KeywordsAgingCohort StudiesFemaleFrailtyHIV InfectionsHIV SeropositivityHospitalizationHumansMalePolypharmacyConceptsVeterans Aging Cohort StudyMedication countDrug-drug interactionsAntiretroviral therapyObservational studyPhysiological frailtyVeterans Affairs Health Services ResearchMore drug-drug interactionsRisk of hospitalisationRisk of admissionAging Cohort StudyHIV-1 RNANon-ART medicationsAdverse health outcomesNational InstituteHealth services researchAdditional medicationObserved medicationActive medicationCause mortalityMore medicationsCohort studyPrescription fillsHIV statusPrescription medications
2014
Comparison of colorectal cancer screening and diagnoses in HIV-positive and HIV-negative veterans
Guest JL, Rentsch CT, Rimland D. Comparison of colorectal cancer screening and diagnoses in HIV-positive and HIV-negative veterans. AIDS Care 2014, 26: 1490-1493. PMID: 25008192, DOI: 10.1080/09540121.2014.933768.Peer-Reviewed Original ResearchConceptsFecal occult blood testingHIV-positive patientsColorectal cancerYounger ageAtlanta VA Medical CenterHIV-negative veteransOccult blood testingHIV-negative controlsHIV-positive casesColorectal cancer screeningPercent of casesVA Medical CenterYears of ageCRC ratesCRC incidenceHIV statusBlood testingCancer screeningMedical CenterHigh incidenceScreening typeAverage ageHIVPatientsColon polyps